{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T08:17:10Z","timestamp":1788337030726,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Netherlands Organization for Scientific Research","award":["452022317"],"award-info":[{"award-number":["452022317"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s10620-024-08809-8","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T02:01:18Z","timestamp":1735869678000},"page":"738-745","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Prior Anti-TNF Exposure Is Associated with an Increased Risk of Short- and Long-Term Colectomy in Acute Severe Ulcerative Colitis"],"prefix":"10.1007","volume":"70","author":[{"given":"Arno R.","family":"Bourgonje","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Posner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Carbonnel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fr\u00e9d\u00e9ric","family":"Colombel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maia","family":"Kayal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"key":"8809_CR1","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.crohns.2010.02.001","volume":"4","author":"LC Dinesen","year":"2010","unstructured":"Dinesen LC, Walsh AJ, Protic MN, et al. The pattern and outcome of acute severe colitis. J Crohns Colitis. 2010;4:431\u2013437. https:\/\/doi.org\/10.1016\/j.crohns.2010.02.001.","journal-title":"J Crohns Colitis."},{"key":"8809_CR2","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/apt.15592","volume":"51","author":"C Dong","year":"2020","unstructured":"Dong C, Metzger M, Holsb\u00f8 E, Perduca V, Carbonnel F. Systematic review with meta-analysis: mortality in acute severe ulcerative colitis. Aliment Pharmacol Ther. 2020;51:8\u201333. https:\/\/doi.org\/10.1111\/apt.15592.","journal-title":"Aliment Pharmacol Ther."},{"key":"8809_CR3","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/gut.2010.216895","volume":"60","author":"S Travis","year":"2011","unstructured":"Travis S, Satsangi J, L\u00e9mann M. Predicting the need for colectomy in severe ulcerative colitis: a critical appraisal of clinical parameters and currently available biomarkers. Gut. 2011;60:3\u20139. https:\/\/doi.org\/10.1136\/gut.2010.216895.","journal-title":"Gut."},{"key":"8809_CR4","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1093\/ecco-jcc\/jjaa265","volume":"15","author":"V Gupta","year":"2021","unstructured":"Gupta V, Mohsen W, Chapman TP, Satsangi J. Predicting Outcome in Acute Severe Colitis-Controversies in Clinical Practice in 2021. J Crohns Colitis. 2021;15:1211\u20131221. https:\/\/doi.org\/10.1093\/ecco-jcc\/jjaa265.","journal-title":"J Crohns Colitis."},{"key":"8809_CR5","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","volume":"2","author":"SC Truelove","year":"1955","unstructured":"Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955;2:1041\u20131048. https:\/\/doi.org\/10.1136\/bmj.2.4947.1041.","journal-title":"Br Med J."},{"key":"8809_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S2468-1253(16)30003-6","volume":"1","author":"JG Williams","year":"2016","unstructured":"Williams JG, Alam MF, Alrubaiy L, et al. Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial. Lancet Gastroenterol Hepatol. 2016;1:15\u201324. https:\/\/doi.org\/10.1016\/S2468-1253(16)30003-6.","journal-title":"Lancet Gastroenterol Hepatol."},{"key":"8809_CR7","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1111\/apt.17731","volume":"58","author":"M Kayal","year":"2023","unstructured":"Kayal M, Meringer H, Martin L, Colombel JF. Systematic review: Scores used to predict outcomes in acute severe ulcerative colitis. Aliment Pharmacol Ther. 2023;58:974\u2013983. https:\/\/doi.org\/10.1111\/apt.17731.","journal-title":"Aliment Pharmacol Ther."},{"key":"8809_CR8","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1136\/gutjnl-2022-327533","volume":"72","author":"A Adams","year":"2023","unstructured":"Adams A, Gupta V, Mohsen W, et al. Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response. Gut. 2023;72:433\u2013442. https:\/\/doi.org\/10.1136\/gutjnl-2022-327533.","journal-title":"Gut."},{"key":"8809_CR9","doi-asserted-by":"publisher","unstructured":"Rivi\u00e8re P, Li Wai Suen C, Chaparro M, et al. Acute severe ulcerative colitis management: unanswered questions and latest insights. Lancet Gastroenterol Hepatol. 2024;9:251\u2013262. https:\/\/doi.org\/10.1016\/S2468-1253(23)00313-8.","DOI":"10.1016\/S2468-1253(23)00313-8"},{"key":"8809_CR10","doi-asserted-by":"publisher","unstructured":"Choy MC, Suen CFLW, Con D, et al. Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial. Lancet Gastroenterol Hepatol. 2024:S2468\u20131253(24)00200\u20130. https:\/\/doi.org\/10.1016\/S2468-1253(24)00200-0.","DOI":"10.1016\/S2468-1253(24)00200-0"},{"key":"8809_CR11","doi-asserted-by":"publisher","first-page":"2626","DOI":"10.3748\/wjg.v16.i21.2626","volume":"16","author":"M Allez","year":"2010","unstructured":"Allez M, L\u00e9mann M. Role of endoscopy in predicting the disease course in inflammatory bowel disease. World J Gastroenterol. 2010;16:2626\u20132632. https:\/\/doi.org\/10.3748\/wjg.v16.i21.2626.","journal-title":"World J Gastroenterol."},{"key":"8809_CR12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.gastha.2023.11.001","volume":"3","author":"J Angkeow","year":"2023","unstructured":"Angkeow J, Rothman A, Chaaban L, Paul N, Melia J. Systematic Review: Outcome Prediction in Acute Severe Ulcerative Colitis. Gastro Hep Adv. 2023;3:260\u2013270. https:\/\/doi.org\/10.1016\/j.gastha.2023.11.001.","journal-title":"Gastro Hep Adv."},{"key":"8809_CR13","doi-asserted-by":"publisher","unstructured":"Carbonnel F, Lavergne A, L\u00e9mann M, et al. Colonoscopy of acute colitis. A safe and reliable tool for assessment of severity. Dig Dis Sci. 1994 Jul;39:1550\u20137. https:\/\/doi.org\/10.1007\/BF02088063.","DOI":"10.1007\/BF02088063"},{"key":"8809_CR14","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1093\/ibd\/izy282","volume":"25","author":"NZ Borren","year":"2019","unstructured":"Borren NZ, Khalili H, Luther J, Colizzo FP, Garber JJ, Ananthakrishnan AN. Second-Look Endoscopy in Hospitalized Severe Ulcerative Colitis: A Retrospective Cohort Study. Inflamm Bowel Dis. 2019;25:750\u2013755. https:\/\/doi.org\/10.1093\/ibd\/izy282.","journal-title":"Inflamm Bowel Dis."},{"key":"8809_CR15","doi-asserted-by":"publisher","unstructured":"Fernandes SR, Santos P, Miguel Moura C, et al. The use of a segmental endoscopic score may improve the prediction of clinical outcomes in acute severe ulcerative colitis. Rev Esp Enferm Dig. 2016;108:697\u2013702. https:\/\/doi.org\/10.17235\/reed.2016.4470\/2016","DOI":"10.17235\/reed.2016.4470\/2016"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08809-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-024-08809-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-024-08809-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T18:41:06Z","timestamp":1739990466000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-024-08809-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["8809"],"URL":"https:\/\/doi.org\/10.1007\/s10620-024-08809-8","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"4 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The corresponding author confirms on behalf of all authors that there have been no involvements that might raise the question of bias in the work reported or in the conclusions, implications, or opinions stated. ARB reports receiving research grants from Janssen Pharmaceuticals and received speaker\u2019s fees from AbbVie and Ferring Pharmaceuticals. JFC reports receiving research grants from AbbVie, Janssen Pharmaceuticals, Takeda, and Bristol Myers Squibb; receiving payment for lectures from AbbVie and Takeda; receiving consulting fees from AbbVie, Amgen, AnaptysBio, Allergan, Arena Pharmaceuticals, Boehringer Ingelheim, Bristol Myers Squibb, Celgene Corporation, Celltrion, Eli Lilly, Ferring Pharmaceuticals, Galmed Research, Glaxo Smith Kline, Genentech (Roche), Janssen Pharmaceuticals, Kaleido Biosciences, Immunic, Invea, Iterative Scopes, Merck, Landos, Microba Life Science, Novartis, Nautilus, Otsuka Pharmaceutical, Pfizer, Protagonist Therapeutics, Prometheus, Sanofi, Seres, Takeda, Teva, TiGenix, and Vifor; and hold stock options in Intestinal Biotech Development. MK has served as a consultant or received advisory board fees from AbbVie, Pfizer, BMS, Janssen, and Fresenius Kabi. The remaining authors disclose no conflicts.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}